Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/3/2025

Safety of Medications in Post-CABG Patients on Dual Antiplatelet Therapy

Dual Antiplatelet Therapy Context

  • The European Society of Cardiology recommends DAPT (aspirin + clopidogrel) for 12 months post-CABG, with a possible duration of 6 months in high bleeding risk patients 1, 2
  • Clopidogrel is the preferred P2Y12 inhibitor in this setting, according to the European Heart Journal 3, 1

Medication-Specific Safety Assessment

  • Paracetamol can be used at the lowest effective dose for the shortest duration (maximum 2-3 grams daily) in patients on DAPT, as recommended by the European Heart Journal 4
  • Chronic high-dose use of paracetamol should be avoided, as it may enhance antiplatelet effects and increase bleeding risk when combined with DAPT, according to the European Heart Journal 4

Critical Safety Considerations

  • The American College of Cardiology recommends adding or continuing a proton pump inhibitor (PPI) for gastrointestinal protection while on DAPT, especially when adding multiple medications that may affect hemostasis 5
  • NSAIDs should be avoided entirely, as they significantly increase bleeding risk and cardiovascular events in patients on DAPT, according to the American College of Cardiology 5
  • Patients on DAPT should be monitored for signs of bleeding (e.g. melena, hematuria, excessive bruising), as recommended by the European Heart Journal 6
  • The European Society of Cardiology recommends continuing Concor (bisoprolol) without interruption unless hemodynamically unstable 3
  • Adequate hydration should be ensured, especially if fever is present, to maintain cardiac output and prevent hypotension with beta-blocker therapy, according to the European Heart Journal 4
  • Patients should be watched for signs of heart failure exacerbation (e.g. dyspnea, edema, orthopnea) as respiratory infections can precipitate decompensation, as recommended by the European Heart Journal 4

Practical Management Algorithm

  • DAPT and Concor should be continued without interruption, according to the European Heart Journal 1, 2
  • A PPI should be prescribed if not already on one, as recommended by the American College of Cardiology 5
  • Paracetamol can be used at reduced doses (500-1000 mg every 6-8 hours, maximum 3 grams daily) for fever/pain control, according to the European Heart Journal 4

Common Pitfalls to Avoid

  • DAPT should not be discontinued for acute illness unless life-threatening bleeding occurs, as recommended by the European Heart Journal 1, 2
  • NSAIDs should not be used for pain/fever control, and paracetamol is the only acceptable option, according to the American College of Cardiology 5
  • High-dose paracetamol should not be used chronically (>3 grams daily for >5 days) due to potential enhancement of antiplatelet effects, as recommended by the European Heart Journal 4

REFERENCES